Review article · 2025 · Open access
The future of pharmaceuticals: Artificial intelligence in drug discovery and development
Journal of Pharmaceutical Analysis, 15(8), 101248 · Published 26 February 2025 · DOI 10.1016/j.jpha.2025.101248
In brief
“The future of pharmaceuticals: Artificial intelligence in drug discovery and development” is a 2025 review article by Chen Fu and Qi Chen, published in Journal of Pharmaceutical Analysis. OpenAlex counts 200 citations as of 15 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Journal of Pharmaceutical Analysis.
- Citations
- 200
- Most cited in
- 2026 (130)
- Field-weighted impact
- 9.90
- References
- 216
- Authors
- 2
Abstract
Artificial Intelligence (AI) is revolutionizing traditional drug discovery and development models by seamlessly integrating data, computational power, and algorithms. This synergy enhances the efficiency, accuracy, and success rates of drug research, shortens development timelines, and reduces costs. Coupled with machine learning (ML) and deep learning (DL), AI has demonstrated significant advancements across various domains, including drug characterization, target discovery and validation, small molecule drug design, and the acceleration of clinical trials. Through molecular generation techniques, AI facilitates the creation of novel drug molecules, predicting their properties and activities, while virtual screening (VS) optimizes drug candidates. Additionally, AI enhances clinical trial efficiency by predicting outcomes, designing trials, and enabling drug repositioning. However, AI's application in drug development faces challenges, including the need for robust data-sharing mechanisms and the establishment of more comprehensive intellectual property protections for algorithms. AI-driven pharmaceutical companies must also integrate biological sciences and algorithms effectively, ensuring the successful fusion of wet and dry laboratory experiments. Despite these challenges, the potential of AI in drug development remains undeniable. As AI technology evolves and these barriers are addressed, AI-driven therapeutics are poised for a broader and more impactful future in the pharmaceutical industry.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Fu, C., & Chen, Q. (2025). The future of pharmaceuticals: Artificial intelligence in drug discovery and development. Journal of Pharmaceutical Analysis, 15(8), 101248. https://doi.org/10.1016/j.jpha.2025.101248
MLA 9
Fu, Chen, and Qi Chen. “The future of pharmaceuticals: Artificial intelligence in drug discovery and development.” Journal of Pharmaceutical Analysis, vol. 15, no. 8, 2025, p. 101248. https://doi.org/10.1016/j.jpha.2025.101248.
Chicago
Fu, Chen and Qi Chen. 2025. “The future of pharmaceuticals: Artificial intelligence in drug discovery and development.” Journal of Pharmaceutical Analysis 15 (8): 101248. https://doi.org/10.1016/j.jpha.2025.101248.
Harvard
Fu, C. and Chen, Q. (2025) ‘The future of pharmaceuticals: Artificial intelligence in drug discovery and development’, Journal of Pharmaceutical Analysis, 15(8), p. 101248. doi:10.1016/j.jpha.2025.101248.
IEEE
C. Fu and Q. Chen, “The future of pharmaceuticals: Artificial intelligence in drug discovery and development,” Journal of Pharmaceutical Analysis, vol. 15, no. 8, p. 101248, 2025, doi: 10.1016/j.jpha.2025.101248.
BibTeX
@article{fu2025future,
title = {{The future of pharmaceuticals: Artificial intelligence in drug discovery and development}},
author = {Fu, Chen and Chen, Qi},
journal = {Journal of Pharmaceutical Analysis},
year = {2025},
volume = {15},
number = {8},
pages = {101248},
doi = {10.1016/j.jpha.2025.101248},
url = {https://doi.org/10.1016/j.jpha.2025.101248}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 1 | |
| 2025 | 69 | |
| 2026 | 130 |
Its field-weighted citation impact is 9.90: it has been cited 9.90 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- artificial intelligence in drug discovery
- drug development
- machine learning
- deep learning
- molecular generation
- virtual screening
- clinical trial design
- drug repurposing
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Fu, C., & Chen, Q. (2025). The future of pharmaceuticals: Artificial intelligence in drug discovery and development. Journal of Pharmaceutical Analysis, 15(8), 101248. https://doi.org/10.1016/j.jpha.2025.101248
How many times has this paper been cited?
200 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Journal of Pharmaceutical Analysis.
Who wrote this paper?
Chen Fu, Qi Chen.
What is the DOI of this paper?
10.1016/j.jpha.2025.101248. The permanent link is https://doi.org/10.1016/j.jpha.2025.101248.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.